Reaction
Product Reconstitution Quality Issue reporting signals
As of the last recalculation, Product Reconstitution Quality Issue appears in 853 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is SOMATROPIN (PRR 68.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Somatropin | 166 | 68.2 | 68.4 |
| Leuprolide Acetate | 120 | 43.8 | 43.8 |
| Teduglutide | 21 | 39.0 | 39.0 |
| Azacitidine For | 16 | 21.9 | 21.9 |
| Naltrexone | 24 | 19.5 | 19.5 |
| Nemolizumab-Ilto | 10 | 19.4 | 19.4 |
| Azacitidine | 17 | 14.2 | 14.3 |
| Alteplase | 6 | 9.8 | 9.8 |